Promethazine

This classification denotes a phenothiazine with the molecular formula C17H20N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FF28EJQ494, chemically known as 10h-phenothiazine-10-ethanamine, n,n,alpha-trimethyl-, radical ion(1+) but generally known as promethazine, which bears US NIH Compound Identifier 4927. European Medicines Agency schedules Promethazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10088MIG. The term PROMETHAZINE is an International Non-Proprietary Name. World Health Organization schedules promethazine in its Anatomical Therapeutic Chemical (ATC) Classification. PROMETHAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule promethazine under HS 29343090 and SITC 51578. As of Q4 2014, PROMETHAZINE remains the US FDA Preferred Term for this commodity. Promethazine bears US NLM identifiers UMLS ID C0033405 and NCI Concept Code C779. SMILES: S1C2C(N(CC(N(C)C)C)C3C1CCCC3)CCCC2.